Article Details

Scopus BioPharma Adds Oligonucleotide Cancer Therapeutics With Olimmune Acquisition

Retrieved on: 2021-06-30 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Scopus BioPharma Adds Oligonucleotide Cancer Therapeutics With Olimmune Acquisition. View article details on hiswai:

Excerpt

Scopus BioPharma Inc (NASDAQ: SCPS) has acquired Los Angeles-based Olimmune Inc for an undisclosed amount. Olimmune is a developer of ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo